Just a week after the 2024 presidential election, Dr. Myechia Minter-Jordan has transitioned into her new position as CEO of ...

BMO Capital Markets analyst Evan Seigerman in a note to investors called Gilead’s third-quarter performance “consistent” and ...

December S&P 500 E-Mini futures (ESZ24) are trending up +2.24% this morning after Republican Donald Trump won the U.S.

December S&P 500 E-Mini futures (ESZ24) are trending up +2.37% this morning as Donald Trump declared victory in the U.S. presidential election, while investors also geared up for the start of the ...

Roche executive Daniel O’Day is to take the helm at Gilead after John Milligan steps down as CEO at the end of this year, the company has announced. Currently CEO of Roche Pharmaceuticals since ...

Crispr Therapeutics recently received FDA and EMA approval for Casgevy. Read why CRSP stock is compelling investment in the ...

Dean Forbes, chief executive of software company Forterro, has been named Britain's most influential black person by The Powerlist 2025. The 45-year-old, who was twice homeless as a teenager ...

The CEO of Microsoft, Satya Nadella, is getting a pay raise. A $30 million one. According to a proxy filing published earlier this week and spotted by NBC, Nadella's compensation for the fiscal ...

Chief Executive Officer of Paratus Sciences, will participate in a panel discussion at the Longwood Healthcare Leaders CEO meeting being held in Boston, Massachusetts from October 28-29 ...

STAT+ subscribers can sign up here to get it delivered to their inbox. The next referendum on Gilead Sciences’ oft-criticized oncology business is approaching. Circle Nov. 5 on your calendars.